Anna Spreafico
Project Leader
Clinician Investigator, Princess Margaret Cancer Centre
Projects
Related News
-
PM2 CAN-IMPACT-IO a national immunotherapy biospecimen collection study has now opened
PM2 CAN-IMPACT-IO is a unique national initiative to measure, predict and assess cancer treatment outcomes in patients who have been treated with immunotherapy. Patients on CCTG clinical trials who co... -
Marathon of Hope Cancer Centres Network and Canadian Cancer Trials Group partner on three pan-Canadian projects aimed at making immunotherapy more effective for cancer patients
A new partnership between the Marathon of Hope Cancer Centres Network (MOHCCN) and the Canadian Clinical Trials Group (CCTG) will support three pan-Canadian research teams aiming to better understand ...
-
Regional Consortia
Princess Margaret Cancer Consortium
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more
-
